Plasma miRNA expression levels in women with preeclampsia and chronic arterial hypertension in the first trimester of pregnancy

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: This study aimed to investigate the expression of several miRNAs in the plasma of patients with chronic arterial hypertension (CAH) without preeclampsia and pregnant women with CAH-associated preeclampsia (CAP) during the first trimester of pregnancy.

Materials and methods: The study included 100 patients: Group 1 (n=58) comprised pregnant women with CAH without preeclampsia, and Group 2 (n=42) included women with CAP. The plasma expression levels of 11 miRNAs were assessed in these patients at 12–14 weeks of gestation using quantitative real-time polymerase chain reaction. Statistical analysis was conducted using the IBM SPSS Statistics software (version 26.0, USA).

Results: Women with CAP exhibited contrasting changes in the expression of five out of 11 plasma miRNAs compared to the group without CAP. The expression levels of miRNA-20a (p<0.001) and miRNA-181a (p<0.001) were significantly decreased in the CAP group. Conversely, the expression levels of miRNA-221 (p<0.001), miRNA-146a (p=0.02), and miRNA-210 (p=0.041) were higher in this group than in women who did not develop preeclampsia.

Conclusion: Statistically significant changes in the expression levels of several miRNAs associated with cardiovascular pathology and placental dysfunction were identified in the first trimester of pregnancy in patients with CAH and CAP.

Full Text

Restricted Access

About the authors

Yurii A. Semenov

Ural Research Institute for Maternity and Child Care, Ministry of Health of the Russian Federation

Email: u-sirius@mail.ru
ORCID iD: 0000-0002-3268-7981

Dr. Med. Sci., Associate Professor, Director

Russian Federation, Yekaterinburg

Vladimir N. Antonov

South Ural State Medical University, Ministry of Health of the Russian Federation

Email: ant-vn@yandex.ru
ORCID iD: 0000-0002-3531-3491

Dr. Med. Sci., Associate Professor, Professor at the Therapy Department of the Institute of Continuing Professional Education

Russian Federation, Chelyabinsk

Evgeniia A. Azarenkova

Ural Research Institute for Maternity and Child Care, Ministry of Health of the Russian Federation

Author for correspondence.
Email: jennysplean@mail.ru
ORCID iD: 0000-0001-9656-350X

Head of the Educational and Methodological Department

Russian Federation, Yekaterinburg

Anna V. Chizhovskaya

Ural Research Institute for Maternity and Child Care, Ministry of Health of the Russian Federation

Email: ms.chizhovskaya@mail.ru
ORCID iD: 0000-0003-1574-1613

Deputy Director for Organizational and Methodological Work and Public Issues

Russian Federation, Yekaterinburg

Yuliya A. Veryaskina

Institute of Molecular and Cell Biology, Siberian Branch of the Russian Academy of Sciences

Email: microrna@inbox.ru
ORCID iD: 0000-0002-3799-9407

PhD, Researcher at the Laboratory of Molecular Genetics, Department of Chromosome Structure and Function

Russian Federation, Novosibirsk

References

  1. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Preeclampsia. Eclampsia. Edema, proteinuria, and hypertensive disorders during pregnancy, childbirth, and the postpartum period. 2024. (in Russian)].
  2. Kametas N.A., Nzelu D., Nicolaides K.H. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Am. J. Obstet. Gynecol. 2022; 226(2S): S1182-95. https://dx.doi.org/10.1016/j.ajog.2020.11.029
  3. DeSisto C.L., Robbins C.L., Ritchey M.D., Ewing A.C., Ko J.Y., Kuklina E.V. Hypertension at delivery hospitalization – United States, 2016–2017. Pregnancy Hypertens. 2021; 26: 65-8. https://dx.doi.org/10.1016/j.preghy.2021.09.002
  4. Greenberg V.R., Silasi M., Lundsberg L.S., Culhane J.F., Reddy U.M., Partridge C. et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am. J. Obstet. Gynecol. 2021; 224(5): 521.e1-11. https://dx.doi.org/10.1016/j.ajog.2020.10.049
  5. Rezk M., Gamal A., Emara M. Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. Hypertens. Pregnancy. 2015; 34(2): 137-44. https://dx.doi.org/10.3109/10641955.2014.982329
  6. Leimena C., Qiu H. Non-coding RNA in the pathogenesis, progression and treatment of hypertension. Int. J. Mol. Sci. 2018; 19(4): 927. https://dx.doi.org/10.3390/ijms19040927
  7. Lopes A.C.S., Macedo A.A., Mendes F.S., Costa I.M., Dusse L.M.S., Alpoim P.N. Changes in microRNA expression associated with preeclampsia: a systematic review. Braz. J. Med. Biol. Res. 2025; 58: e13988. https://dx.doi.org/10.1590/1414-431X2025e13988
  8. Никитина Н.А., Сидорова И.С., Райгородская М.П., Морозова Е.А., Тимофеев С.А., Агеев М.Б., Амирасланова Н.И. Эпигенетические механизмы развития преэклампсии: роль плазменных микроРНК. Архив акушерства и гинекологии им. В.Ф. Снегирёва. 2024; 11(2): 179-92. [Nikitina N.А., Sidorova I.S., Raygorodskaya M.Р., Morozova E.А., Timofeev S.А., Ageev M.В., Amiraslanova N.I. Epigenetic mechanisms of preeclampsia: Role of plasma microRNAs. V.F. Snegirev Archives of Obstetrics and Gynecology. 2024; 11(2): 179-92 (in Russian)]. https://dx.doi.org/10.17816/aog623622
  9. Семенов Ю.А., Казачков Е.Л., Веряскина Ю.А., Чижовская А.В. Профиль экспрессии микроРНК в плазме крови беременных женщин с высоким и низким риском спонтанных преждевременных родов и перинатальных потерь. Южно-Уральский медицинский журнал. 2021; 2: 18-23. [Semyonov Yu.A., Kazachkov E.L., Veryaskina Yu.A., Chizhovskaya A.V. MicroRNA expression profile in the blood plasma of pregnant women with high and low risk of spontaneous preterm birth and perinatal loss. South Ural Medical Journal. 2021; 2: 18-23 (in Russian)].
  10. Борис Д.А., Шмаков Р.Г. Преэклампсия: современные концепции патогенеза. Акушерство и гинекология. 2022; 12: 12-7. [Boris D.A., Shmakov R.G. Preeclampsia: modern concepts of pathogenesis. Obstetrics and Gynecology. 2022; (12): 12-7 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.213
  11. Hayder H., O'Brien J., Nadeem U., Peng C. MicroRNAs: crucial regulators of placental development. Reproduction. 2018; 155(6): R259-71. https://dx.doi.org/10.1530/REP-17-0603
  12. Luizon M.R., Conceição I.M.C.A., Viana-Mattioli S., Caldeira-Dias M., Cavalli R.C., Sandrim V.C. Circulating MicroRNAs in the second trimester from pregnant women who subsequently developed preeclampsia: potential candidates as predictive biomarkers and pathway analysis for target genes of miR-204-5p. Front. Physiol. 2021; 12: 678184. https://dx.doi.org/10.3389/fphys.2021.678184
  13. Celic T., Metzinger-Le Meuth V., Six I., Massy ZA., Metzinger L. The mir-221/222 cluster is a key player in vascular biology via the fine-tuning of endothelial cell physiology. Curr. Vasc. Pharmacol. 2017; 15(1): 40-6. https://dx.doi.org/10.2174/1570161114666160914175149
  14. Naderi-Meshkin H., Setyaningsih W.A.W. Endothelial cell dysfunction: onset, progression, and consequences. Front. Biosci. (Landmark Ed). 2024; 29(6): 223. https://dx.doi.org/10.31083/j.fbl2906223
  15. Alexandru N., Constantin A., Nemecz M., Comariţa IK., Vîlcu A., Procopciuc A. et al. Hypertension associated with hyperlipidemia induced different microRNA expression profiles in plasma, platelets, and platelet-derived microvesicles; effects of endothelial progenitor cell therapy. Front. Med. (Lausanne). 2019; 6: 280. https://dx.doi.org/10.3389/fmed.2019.00280
  16. Yang Y., Li H., Ma Y., Zhu X., Zhang S., Li J. MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed. Pharmacother. 2019; 109: 127-34. https://dx.doi.org/10.1016/j.biopha.2018.10.009
  17. Щербаков В.И., Поздняков И.М., Ширинская А.В. Уровень фактора-1α, индуцируемого гипоксией, и ассоциированных с ним молекул при преэклампсии. Российский вестник акушера-гинеколога. 2025; 25(1): 5-10. [Shcherbakov V.I., Pozdnyakov I.M., Shirinskaya A.V. Level of hypoxia-inducible factor-1α and associated molecules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025; 25(1): 5-10 (in Russian)]. https://dx.doi.org/10.17116/rosakush2025250115
  18. Jaszczuk I., Koczkodaj D., Kondracka A., Kwaśniewska A., Winkler I., Filip A. The role of miRNA-210 in pre-eclampsia development. Ann. Med. 2022; 54(1): 1350-6. https://dx.doi.org/10.1080/07853890.2022.2071459
  19. Youssef H.M.G., Marei E.S. Association of MicroRNA-210 and MicroRNA-155 with severity of preeclampsia. Pregnancy Hypertens. 2019; 17: 49-53. https://doi.org/10.1016/j.preghy.2019.05.010
  20. Lumbers E.R., Delforce S.J., Arthurs A.L., Pringle K.G. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front. Endocrinol. (Lausanne). 2019; 10: 563. https://dx.doi.org/10.3389/fendo.2019.00563
  21. Takeda Y., Demura M., Yoneda T., Takeda Y. Epigenetic regulation of the renin-angiotensin-aldosterone system in hypertension. Int. J. Mol. Sci. 2024; 25(15): 8099. https://doi.org/10.3390/ijms25158099
  22. Артемьева К.А., Низяева Н.В., Баев О.Р., Романов А.Ю., Хлестова Г.В., Болтовская М.Н., Щеголев А.И., Кактурский Л.В. Регуляция ренин-ангиотензин-альдостероновой системы плаценты при ранней и поздней преэклампсии. Доклады Российской академии наук. Науки о жизни. 2022; 507(1): 475-82. [Artemieva K.A., Nizyaeva N.V., Baev O.R., Romanov A.Yu., Khlestova G.V., Boltovskaya M.N., Shchegolev A.I., Kakturskiy L.V. Regulation of the placental renin-angiotensin-aldosterone system in early and late onset preeclampsia. Reports of the Russian Academy of Sciences. Life sciences. 2022; 507(1): 475-82 (in Russian)]. https://dx.doi.org/10.31857/S2686738922060026
  23. Lv B., He S., Li P. Jiang S., Li D., Lin J. et al. MicroRNA-181 in cardiovascular disease: emerging biomarkers and therapeutic targets. FASEB J. 2024; 38(9): e23635. https://doi.org/10.1096/fj.202400306R
  24. Jackson K.L., Gueguen C., Lim K., Eikelis N., Stevenson E.R., Charchar F.J. et al. Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice. Hypertens. Res. 2020; 43(11): 1152-64. https://doi.org/10.1038/s41440-020-0453-x
  25. Marques F.Z., Romaine S.P., Denniff M., Eales J., Dormer J., Garrelds I.M. et al. Signatures of miR-181a on the renal transcriptome and blood pressure. Mol. Med. 2015; 21(1): 739-48. https://dx.doi.org/10.2119/molmed.2015.00096
  26. Hromadnikova I., Kotlabova K., Krofta L. Cardiovascular disease-associated MicroRNA dysregulation during the first trimester of gestation in women with chronic hypertension and normotensive women subsequently developing gestational hypertension or preeclampsia with or without fetal growth restriction. Biomedicines. 2022; 10(2): 256. https://dx.doi.org/10.3390/biomedicines10020256
  27. Lin W., Teng S.W., Lin T.Y. Lovel R., Sung H.Y., Chang W.Y. et al. Combinatorial analysis of circulating biomarkers and maternal characteristics for preeclampsia prediction in the first and third trimesters in Asia. Diagnostics (Basel). 2022; 12(7): 1533. https://dx.doi.org/10.3390/diagnostics12071533
  28. Никитина Н.А., Сидорова И.С., Райгородская М.П., Морозова Е.А., Тимофеев С.А., Агеев М.Б., Амирасланова Н.И. Роль микроРНК, ассоциированных с кардиоваскулярными заболеваниями и плацентарными нарушениями, в развитии преэклампсии. Вопросы гинекологии, акушерства и перинатологии. 2025; 24(2): 5-19. [Nikitina N.A., Sidorova I.S., Raigorodskaya M.P., Morozova E.A., Timofeev S.A., Ageev M.B., Amiraslanova N.I. Role of microRNAs associated with cardiovascular disease and placental abnormalities in the development of pre-eclampsia. Gynecology, Obstetrics and Perinatology. 2025; 24(2): 5-19 (in Russian)]. https://dx.doi.org/10.20953/1726-1678-2025-2-5-19
  29. Wang Y., Zhang Y., Wang H., Wang J., Zhang Y., Wang Y. et al. Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. Int. J. Biol. Sci. 2014; 10(9): 973-82. https://dx.doi.org/10.7150/ijbs.9088
  30. Hu T.X., Wang G., Guo X.J., Sun Q.Q., He P., Gu H. et al. MiR 20a, -20b and -200c are involved in hydrogen sulfide stimulation of VEGF production in human placental trophoblasts. Placenta. 2016; 39: 101-10. https://dx.doi.org/10.1016/j.placenta.2016.01.019

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Bionika Media